News

Filter

Current filters:

Cardio-vascular

26 to 35 of 940 results

Tianyin Pharma to form strategic alliance with Buchang Pharma

15-01-2015

Tianyin Pharmaceutical says TPI and Buchang Pharmaceutical plan to establish Tianyin-Buchang Strategic…

Buchang PharmaceuticalCardio-vascularChinaGingko MihuanMergers & AcquisitionsPharmaceuticalProductionTianyin Pharmaceutical

Aegerion Pharma under SEC investigation

Aegerion Pharma under SEC investigation

14-01-2015

US biotech firm Aegerion Pharmaceuticals has revealed it is the subject of a US Securities and Exchange…

Aegerion PharmaceuticalsBiotechnologyBrazilCardio-vascularJuxtapidLegalMarkets & MarketingRare diseasesUSA

AstraZeneca study of Brilinta meets primary endpoint

AstraZeneca study of Brilinta meets primary endpoint

14-01-2015

Anglo-Swedish drug major AstraZeneca has announced its PEGASUS-TIMI 54 study of Brilinta (ticagrelor)…

AstraZenecaBrilintaCardio-vascularPharmaceuticalResearch

More than one in 10 adults receiving inappropriate aspirin therapy for cardio disease

More than one in 10 adults receiving inappropriate aspirin therapy for cardio disease

14-01-2015

More than one in 10 US adults are receiving inappropriate aspirin therapy for the primary prevention…

AspirinCardio-vascularHealthPharmaceuticalResearch

Russia’s Nanolek commissions plant for production of nano-based drugs

12-01-2015

Russia's Nanolek has officially commissioned a new facility for the production of drugs for the treatment…

Antibiotics and Infectious diseasesCardio-vascularNanolekOncologyPharmaceuticalProductionRussia

EMA accepts Sanofi and Regeneron's MMA for Praluent for review

EMA accepts Sanofi and Regeneron's MMA for Praluent for review

12-01-2015

French drug major Sanofi and US biotech company Regeneron have announced that the European Medicines…

alirocumabBiotechnologyCardio-vascularEuropeRegeneronRegulationSanofi

Sanofi and Regeneron’s alirocumab meets endpoints in cholesterol study

Sanofi and Regeneron’s alirocumab meets endpoints in cholesterol study

09-01-2015

French pharma major Sanofi and Regeneron Pharmaceuticals today announced that two new ODYSSEY trials,…

alirocumabBiotechnologyCardio-vascularRegeneron PharmaceuticalsResearchSanofi

FDA approves Daiichi Sankyo’s anti-clotting drug Savaysa

09-01-2015

The US Food and Drug Administration late yesterday approved Japanese drug major Daiichi Sankyo’s anti-clotting…

Cardio-vascularDaiichi SankyoedoxabanPharmaceuticalRegulationSavaysaUSA

26 to 35 of 940 results

Back to top